智通财经7月15日电， 香港交易所信息显示，纽约梅隆银行在金山云的持股比例于07月11日从10.03%升 至10.12%。 ...

智通财经7月15日电，香港交易所信息显示，摩根大通在中国财险的持股比例于07月09日从8.26%升至 9.16%，平均股价为14.8739港元。 ...

智通财经7月14日电，香港交易所信息显示，贝莱德在美团-W的持股比例于07月08日从5.84%升至 6.13%。 ...

香港交易所信息显示， 贝莱德在 理想汽车-W的持股比例于07月08日从5.07%降至4.95%。 ...

Core Viewpoint - Bank of America has reduced its stake in Bilibili-W from 6.25% to 6.07% as of July 8 [1] Company Summary - The reduction in Bank of America's holding indicates a slight decrease in confidence or a strategic shift regarding Bilibili-W [1]

Group 1 - The core viewpoint is that Hong Kong Exchanges and Clearing Limited (HKEX) is expected to report strong earnings growth in Q2 2025, with a projected year-on-year increase of 31% and a quarter-on-quarter increase of 1% [1] - For Q2 2025, total revenue is anticipated to reach HKD 68.7 billion, representing a year-on-year increase of 27% and a flat quarter-on-quarter performance, while the main fee income is expected to be HKD 54.8 billion, up 30% year-on-year [1] - The trading activity in spot and commodity markets remains high, while derivatives trading shows a marginal decline; spot trading ADT is projected to be HKD 2,381 billion, a 96% increase year-on-year [1] Group 2 - The IPO market is expected to remain active, with 27 IPOs completed in Q2 2025, raising HKD 884 billion, which is a significant increase of 932% year-on-year [1] - The investment income is projected to grow by 15% year-on-year to HKD 13.9 billion, driven by a favorable interest rate environment and increased margin requirements in a high volatility market [1] - The long-term growth potential for HKEX is supported by the expected increase in daily trading volume, with a projected CAGR of 14% for the next decade, leading to a profit CAGR of 12% [2] Group 3 - The current valuation of HKEX is at 34x/32x P/E for 2025/2026, with a target price of HKD 465, indicating an 11% upside potential [2]

Core Viewpoints - Hong Kong Stock Exchange (HKEX) reported a significant increase in market activity, with the average daily turnover (ADT) reaching HKD 2,376.77 billion in Q2 2025, a year-on-year increase of 95.46% [1][2][3] - The influx of southbound capital has contributed to high trading volumes, with a total net purchase of HKD 2,728.63 billion from April to June 2025, marking a 24.77% increase year-on-year [3][4] - The number of new IPOs in Q2 2025 rose to 27, up by 9 from the same period last year, with total IPO fundraising amounting to HKD 880.43 billion, a year-on-year increase of 906.67% [1][3][5] Market Performance - As of June 2025, the market capitalization of the Hong Kong securities market stood at HKD 42.68 trillion, reflecting a 6.84% increase quarter-on-quarter and a 32.82% increase year-on-year [2] - The Hang Seng Index increased by 4.12% in Q2 2025, while the Hang Seng Tech Index experienced a slight decline of 1.70% [2] IPO and Trading Activity - The surge in IPO activity was driven by major A-share companies listing in Hong Kong, including notable firms like CATL and Hengrui Medicine, which collectively raised HKD 737.72 billion, accounting for 83.79% of the total IPO fundraising in Q2 [3][5] - Derivatives and commodity contracts saw increased trading volumes due to heightened demand for risk hedging, with average daily trading volumes for futures and options reaching 1.54 million contracts in Q2, a 15.34% increase year-on-year [3][4] Investment and Future Outlook - Despite a decline in investment returns due to lower HIBOR rates, the overall yield remains high, with expectations of continued growth in Q2 performance [4][5] - The company maintains a "buy" rating, projecting a target price of HKD 480.08 per share based on a 40x PE ratio for 2025, indicating a favorable outlook for future market activity and valuation recovery [7]

Investment Rating - The investment rating for Hong Kong Exchanges is "Buy" with a 12-month target price of HK$450, indicating an upside potential of 10.2% from the current price of HK$408.20 [3][2]. Core Insights - The report revises the earnings per share (EPS) estimates for Hong Kong Exchanges for 2025E, 2026E, and 2027E down by -1.8%, -1.5%, and -1.2% respectively, based on updated volume data for June 2025 and July 2025 [1][2]. - The investment income estimates have also been updated to reflect the latest HIBOR forecasts, but the overall investment thesis remains unchanged [1]. - The target price is derived from a 3-stage Dividend Discount Model (DDM), implying a price-to-earnings (P/E) ratio of 37X for 2026E [2][3]. Financial Projections - Market capitalization is reported at HK$517.5 billion (approximately $65.9 billion) [3]. - Revenue projections for the upcoming years are as follows: 2024E at HK$22,374 million, 2025E at HK$25,351.9 million, 2026E at HK$26,573 million, and 2027E at HK$28,025.7 million [3]. - EPS estimates are revised to HK$10.32 for 2025E, HK$11.49 for 2026E, and HK$12.04 for 2027E [3]. - The report indicates a dividend per share (DPS) of HK$9.26 for 2025E, with a projected dividend yield of 3.5% [3]. Risks and Methodology - The report identifies potential downside risks including increased competition from onshore capital markets, lower trading velocity in the cash market, fee pressure from reduced fees in China, and a sustained deflationary environment in China [2]. - The methodology for the target price is based on a 3-stage DDM approach, which is a standard valuation method used in the industry [2].

智通财经7月10日电，香港交易所信息显示，贝莱德在药明生物的持股比例于07月04日从5.26%降至 4.91%。 ...

Core Viewpoint - The report from CICC maintains the earnings forecast for Hong Kong Exchanges and Clearing Limited (HKEX) unchanged, with a target price of HKD 465, indicating an 11% upside potential based on projected P/E ratios [1] Group 1: Earnings Forecast and Performance - HKEX is expected to report a 2Q25 revenue of HKD 6.87 billion, reflecting a year-on-year increase of 27% and a quarter-on-quarter flat performance, with core fee income projected to rise by 30% year-on-year [1] - For the first half of the year, total revenue and profit are anticipated to increase by 29% and 34% respectively, reaching HKD 13.73 billion and HKD 8.20 billion [1] Group 2: Trading Activity Insights - The report highlights sustained high activity in spot and commodity trading, with a marginal decline in derivatives trading; 2Q average daily turnover (ADT) is expected to be HKD 238.1 billion, up 96% year-on-year [2] - The number of IPOs in 2Q reached 27, raising HKD 88.4 billion, marking a significant increase of 932% year-on-year [2] Group 3: Investment Income and Market Conditions - Investment income is projected to grow by 15% year-on-year to HKD 1.39 billion, driven by a favorable margin environment despite a decline in HIBOR rates [3] - The report notes that the decline in short-term interest rates may enhance margin income, supported by increased collateral requirements in a high-volatility market [3] Group 4: Long-term Growth Potential - The dual resonance of "assets + funds" is expected to enhance HKEX's mid-to-long-term value, with potential increases in market capitalization from "A+H" listings and the return of Chinese concept stocks [4] - If the average daily turnover reaches HKD 210 billion by 2025, HKEX's profit could grow by 18% to HKD 15.4 billion, with a projected CAGR of 14% for ADT over the next decade [4]